The Genomics of Drug Sensitivity in Cancer (GDSC) database and the Cancer Therapeutics Response Portal (CTRP) were used to evaluate the sensitivity and resistance of SLK, MRPL51, and PRC1-targeting drugs. This evidence concerns the gene PRC1 and cancer.